- Report
- March 2023
- 134 Pages
Global
From €5252EUR$5,950USD£4,535GBP
- Report
- October 2023
- 195 Pages
Global
From €5252EUR$5,950USD£4,535GBP
- Report
- December 2024
- 200 Pages
Global
From €3310EUR$3,750USD£2,858GBP
- Report
- November 2023
- 190 Pages
Global
From €3972EUR$4,500USD£3,430GBP
- Report
- July 2023
- 78 Pages
United States
From €3089EUR$3,500USD£2,668GBP
- Report
- December 2024
- 200 Pages
Global
From €3310EUR$3,750USD£2,858GBP
- Report
- October 2024
- 200 Pages
Global
From €3310EUR$3,750USD£2,858GBP
- Report
- October 2024
- 200 Pages
Global
From €3310EUR$3,750USD£2,858GBP
- Report
- January 2024
- 200 Pages
Global
From €3663EUR$4,150USD£3,163GBP
- Report
- July 2024
- 120 Pages
Global
From €4193EUR$4,750USD£3,621GBP
- Report
- February 2024
- 120 Pages
Global
From €4193EUR$4,750USD£3,621GBP
- Report
- April 2023
- 134 Pages
Global
From €4193EUR$4,750USD£3,621GBP
- Report
- July 2024
- 150 Pages
Global
From €3310EUR$3,750USD£2,858GBP
- Report
- July 2024
- 150 Pages
Global
From €3310EUR$3,750USD£2,858GBP
- Report
- July 2024
- 150 Pages
Global
From €3310EUR$3,750USD£2,858GBP
- Report
- May 2023
- 120 Pages
Global
From €3972EUR$4,500USD£3,430GBP
- Report
- June 2025
- 250 Pages
India
From €2462EUR$2,789USD£2,126GBP
- Report
- October 2024
- 200 Pages
Global
From €4368EUR$4,949USD£3,772GBP
- Report
- May 2024
- 106 Pages
North America
From €3045EUR$3,450USD£2,630GBP
From €3178EUR$3,600USD£2,744GBP

A diagnostic biomarker is a biological molecule or gene that is used to identify a particular disease or condition. It is used to diagnose, monitor, and predict the progression of a disease or condition. Diagnostic biomarkers are used to detect the presence of a disease or condition, to determine the severity of the disease or condition, and to monitor the effectiveness of treatments. Diagnostic biomarkers are used in a variety of medical fields, including oncology, neurology, cardiology, and infectious diseases.
Diagnostic biomarkers are typically identified through a variety of methods, including genetic sequencing, proteomics, and metabolomics. These methods allow for the identification of biomarkers that are specific to a particular disease or condition.
The diagnostic biomarker market is a rapidly growing field, with many companies developing and marketing diagnostic biomarkers. Companies in this market include Illumina, Thermo Fisher Scientific, Qiagen, Roche, and Agilent Technologies. Show Less Read more